Protection of Ivabradine Combined with Trimetazidine on Myocardial Injury after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease Evaluated by Magnetic Resonance Image under Convolutional Neural Network
Table 3
Contrast of cTnI, hs-CRP, MDA, and SOD before and after treatment.
Index
IBD + TMZ group
TMZ group
cTnI (ng/mL)
Before
1.71 ± 0.26
1.70 ± 0.27
After
0.42 ± 0.05
0.97 ± 0.08
Hs-CRP (mg/L)
Before
16.27 ± 1.73
16.31 ± 1.82
After
7.17 ± 0.42
11.50 ± 1.01
sICAM-1 (mg/L)
Before
263.14 ± 36.63
259.37 ± 31.18
After
158.81 ± 21.55
216.59 ± 25.65
MDA (µmoL/L)
Before
8.56 ± 1.16
8.53 ± 1.21
After
4.37 ± 0.38
6.83 ± 0.68
SOD (U/mL)
Before
62.27 ± 5.97
63.17 ± 6.08
After
88.94 ± 9.17
71.26 ± 8.85
ET-1 (ng/L)
Before
46.65 ± 6.22
47.06 ± 6.15
After
35.73 ± 5.82
43.08 ± 5.96
Note. In contrast to before treatment within group, ; in contrast to TMZ group in the same period, .
